Ann: Final Patient in Cohort Demonstrates Tumour Marker Reduction, page-49

I agree with the points made regarding amount of shares on issue, however the reality is if this company succeed in what they are trying to acheive then there is nothing that can hold back the SP.
Many on here have a very here and now view, there has been a steady increase in the last couple of months. I think because there is now some traction. With the hopefull announcment around who the Jap Pharma is and then the exposure in the US at the convention, added to that more trial progress we should see steady rises in the SP.
This is not going to make you wealthy overnight but it does deserve a higher SP. I think there is a hangover with investors as there was an expectation over 12 months ago that the SP was heading to 5c but it did not so there is a more cautious approach. If you believe this will succeed then count your blessings as you can still aquire. If you don't well average down and look for an exit with minimal loss.